top of page

Sources

Material sources are listed below.

 

Coming soon
About Herd Immunity

1.Influenza Virus: Immunity and Vaccination Strategies. Comparison of the Immune Response to Inactivated and Live, Attenuated Influenza Vaccines - Cox - 2004 - Scandinavian Journal of Immunology - Wiley Online Library
 

2. http://europepmc.org/articles/PMC3693492
 

3. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3404712

​

4. https://www.ncbi.nlm.nih.gov/pubmed/24277828

​

5. https://www.cdc.gov/tetanus/about/index.html

​

6. https://www.ncbi.nlm.nih.gov/pubmed/22532797    

​

7. https://www.nejm.org/doi/full/10.1056/NEJMoa054960     

​

8. https://www.nejm.org/doi/full/10.1056/NEJMoa1703309

​

9. https://www.ncbi.nlm.nih.gov/pubmed/23442590

​

10. https://ahrp.org/former-merck-scientists-sue-merck-alleg-

          ing-mmr-vaccine-efficacy-fraud

​

11. https://www.ncbi.nlm.nih.gov/pubmed/9850133

​

12. https://academic.oup.com/aje/article-abstract/120/1/39/98627

​

13. https://pmc.ncbi.nlm.nih.gov › articles › PMC3905323 

​

14.http://business.financialpost.com/fp-comment/junk-science-week-vaccinating-the-herd

​

15. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930734

​

16. https://jid.oxfordjournals.org/content/early/2013/04/29/infdis.jit143.full.

 

Waning antibodies from MMR

17. https://www.sciencedaily.com/releases/2015/06/150625130251.htm

​

18. http://www.ncbi.nlm.nih.gov/pubmed/22423127

​

19.http://www.greenmedinfo.com/blog/2013-measles-outbreak-failing-vaccine-not-failure-vaccinate1

​

20. http://www.ncbi.nlm.nih.gov/pubmed/8053748

​

21. http://dx.doi.org/10.1542/peds.2014-3358

​

22. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930734

​

23.https://jid.oxfordjournals.org/content/early/2013/04/29/infdis.jit143.full.

 

MMR maternal antibodies 

24. https://www.sciencedaily.com/releases/2015/06/150625130251.htm

​

25. http://dx.doi.org/10.1542/peds.2014-3358

​

26. https://pubmed.ncbi.nlm.nih.gov › 23413420

 

27. https://pubmed.ncbi.nlm.nih.gov › 22423139

​

28. https://pubmed.ncbi.nlm.nih.gov › 20386731

​

29. Infection of mice with a human influenza A/H3N2 virus induces ... - PubMed

​

30. https://pmc.ncbi.nlm.nih.gov › articles › PMC3888271

​

31. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model - PubMed

​

32. https://pubmed.ncbi.nlm.nih.gov › 2278542

​

33. Tetanus: Causes and How It Spreads | Tetanus | CDC

​

34. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model - PubMed

​

35. Vaccine waning and mumps re-emergence in the United States - PMC

​

36. Former Merck Scientists Sue Merck Alleging MMR Vaccine Efficacy Fraud – Alliance for Human Research Protection

​

37. https://www.rescuepost.com/files/59-opinion.pdf

​

38.https://www.huffpost.com/archive/ca/entry/merck-whistleblowers_b_5881914

​

39. The Re-Emergence of Measles in Developed Countries: Time to Develop the Next-Generation Measles Vaccines? - PMC

​

40. Hepatitis B Basics | Hepatitis B | CDC

​

41. http://www.pnas.org/content/early/2018/01/17/1716561115

​

42. The New England Journal of Medicine: Loss of Vaccine-Induced Immunity to Varicella over Time

https://www.nejm.org/doi/full/10.1056/nejmoa064040

​

43. PubMed Central; Successes and Challenges in Varicella Vaccine

https://www.nejm.org/doi/full/10.1056/nejmoa064040

​

44. Vaccine Types | HHS.gov

COVID - WYNTK.PNG

May 2021
COVID - What You Need To Know

  1. Doshi P. Will covid-19 vaccines save lives? Current trials aren’t designed to tell us. BMJ. 2020;371:m4037. https:// www.bmj.com/content/371/bmj.m4037
     

  2. Haseltine WA. Covid-19 vaccine protocols reveal that trials are designed to suc- ceed. Forbes, September 23, 2020. 
    https://www.forbes.com/sites/williamhasel- tine/2020/09/23/covid-19-vaccine-protocols-reveal-that-trials-are- designed-to-suc- ceed/?sh=5da0663d5247
     

  3. Brownstein D, Ng R, Rowen R et al. A novel approach to treating COVID-19 using nutri- tional and oxidative therapies. Science, Public Health Policy, and the Law. 2020;2:4-22.  
    https://ozonewithoutborders.ngo/wp-content/ uploads/2020/07/Novel-Approach-to- Covid-19.pdf
     

  4. Jackson LA, Anderson EJ, Rouphael NG et al. An mRNA vaccine against SARS-CoV-2 – preliminary report. New England Journal of Medicine. 2020;383(20):1920-1931. 
    https://www.nejm.org/doi/full/10.1056/NEJMoa2022483
     

  5. Allen A, Szabo L. NIH “very concerned” about serious side effect in coronavirus vaccine trial. Scientific American, September 15, 2020. 
    https://www.scientificamerican.com/ article/nih-very-concerned-about-serious-side-effect-in- coronavirus-vaccine-trial
     

  6. Mayer A. Leading COVID vaccine candidates plagued by safety concerns. The Defender, November 13, 2020. 
    https://childrenshealthdefense.org/defender/covid-vaccine-can- didates-safety-concerns/?itm_term=home
     

  7. U.S. Food and Drug Administration. Vaccines and Related Biological Products Advisory Committee, October 22, 2020 Meeting Presentation, slide #16. 
    https://www.green- medinfo.com/blog/covid-19-vaccine-bombshell-fda- documents-reveal-death-21-seri- ous-conditions-possi1
     

  8. Reals T. U.K. warns against giving Pfizer vaccine to people prone to severe allergic reactions. CBS News, December 9, 2020. 
    https://www.cbsnews.com/amp/news/ covid-vaccine-pfizer-shot-uk-warning-people-with- history-of-significant-allergic-reac- tions/#app
     

  9. https://www.fda.gov/media/144245/download 
    page 42
     

  10. Public Readiness and Emergency Preparedness Act. COVID-19 PREP Act Declarations. 
    https://www.phe.gov/Preparedness/legal/prepact/Pages/default.aspx
     

  11. Lyons-Weiler J. Pathogenic priming likely contributes to serious and critical illness and mortality in COVID-19 via autoimmunity. Journal of Translational Autoimmunity.
    2020;3:100051. 
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7142689
     

  12. Khemlani A. Fauci: Early COVID-19 vaccines will only prevent symptoms, not block the virus. Yahoo! Finance, October 26, 2020. 
    https://finance.yahoo.com/news/fauci-vaccines-will-only-prevent-symptoms-not-block-the-virus-195051568.html
     

  13. Scipioni J. Dr. Fauci says masks, social distancing will still be needed after a Covid-19 vaccine—here’s why. CNBC, November 16, 2020. 
    https://www.cnbc.com/2020/11/16/ fauci-why-still-need-masks-social-distancing-after-covid-19-vaccine.html
     

  14. Centers for Disease Control and Prevention. COVID-19 pandemic planning scenarios. Updated September 10, 2020. 
    https://www.cdc.gov/coronavirus/2019-ncov/hcp/planning-scenarios.html
     

  15. Petition/motion for administrative/regulatory action regarding confirmation of efficacy end points and use of data in connection with the following clinical trials. Dr. Wolfgang Wodarg and Dr. Michael Yeadon, petitioners. Filed with European Medicines Agency, December 1, 2020. 
    https://healthimpactnews.com/wp- content/uploads/ sites/2/2020/12/Wodarg_Yeadon_EMA_Petition_Pfizer_Trial_FINAL_01DEC2020_ EN_unsigned_with_Exhibits.pdf
     

  16. AMA, Ethics, Informed Consent 
    https://www.ama-assn.org/delivering-care/ethics/informed-consent
     

  17. Int J Clin Pract. 2020 Oct 28 : e13795., PDF 
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645850/pdf/IJCP-9999-e13795.pdf
     

  18. Front. Microbiol., 05 December 2018 
    https://www.frontiersin.org/articles/10.3389/fmicb.2018.02991/full
     

  19. PNAS.org April 14, 2020 117 (15) 8218-8221 
    https://www.pnas.org/content/117/15/8218
     

  20. JCI Insight February 21, 2019 
    https://insight.jci.org/articles/view/123158

Schedule-2019-PostCard1.PNG
Schedule-2019-PostCard2.PNG

August 2019

Vaccine Schedule Comparison Post Card

54% of our children have chronic illness: https://www.ncbi.nlm.nih.gov/pubmed/21570014?fbclid=IwAR1icXzyPrjy0E9Kr4EqiWMEhAA-4Na38xC-e5HOA835ggPeuIIIF_as71U

​

1 in 36 autism:

https://www.cdc.gov/nchs/products/databriefs/db291.htm  

and

https://www.askdrsears.com/topics/autism/autism-rate-jumps-1-36-children-1-28-boys?fbclid=IwAR27M4lUFO7AXaYQdZRcE-I-BenZQ4PtXV1LErjsYjGjFVfdxmYhAZdxHx4

​

8% or 1 in 12 have food allergies:

https://pediatrics.aappublications.org/content/142/6/e20181235

​

14% are in special education: https://nces.ed.gov/programs/coe/indicator_cgg.asp?fbclid=IwAR3PllXZ9cvlgJUfYym_nlM1Vqz4lKK_Gu8Wyr8pmEZtTrPvU0mORqYV1c8

​

1 in 285 will be diagnosed with cancer:

https://www.acco.org/wp-content/uploads/2014/11/ACS-Special-Report-2014.pdf

​

1 in 26 will develop epilepsy: https://www.aesnet.org/for_patients/facts_figures?fbclid=IwAR2jVD3yKJHYfNQayUDfdCnQZlaS4yiu-_DUBmgkS8GCuGVvDzVUI3LLvnQ#Eight

 

1 in 12 have asthma:

https://www.aafa.org/asthma-facts

 

1 in 5 have learning disabilities:

https://www.ncld.org/archives/blog/the-state-of-ld-understanding-the-1-in-5

 

Before you go...

Writing on a Notebook

Check Out Our Vaccine Research Resources 

Doctor's Appointment

Find Providers in Support of Vaccine Choice

Vaccinating A Child

NVIC's Ask 8 Before Your Vaccinate

3D Scans

How to Report a Vaccine Injury

Connect with MVC Partners

Former Feds Group Freedom Foundation logo.png
VITA.png
  • Rumble logo
  • Instagram - White Circle
  • X formally Twitter white icon
  • Facebook
  • YouTube - White Circle

©2025 All rights reserved.

 

Michigan for Vaccine Choice (MVC) is a 501(c)(3) organization dedicated to providing educational information about the subject of vaccinations, while protecting and supporting individuals and parents to make vaccine decisions in Michigan.

​

​This website and all materials are for educational purposes only. The information on this website is not intended to replace a one-on-one relationship with a qualified health care professional and is not intended as medical or legal advice. 

​

Tax ID: 47-5401416

Privacy       Sources       Terms      Volunteers

Our members, volunteers, and donors are the fuel that power this organization. We can use free survey templates to constantly keep in touch with them, understand their expectations and work towards their satisfaction with this simple yet robust tool.

bottom of page